A specific form of breast cancer may be cured in just 11 days, if the finding of a short-term trial is any indication.
If corroborated by other trials, the breakthrough will help scientists to design a better treatment option for the patients and may lead to fewer women needing chemotherapy.
Breast cancer is one of the most common forms of cancer that affects more than a million women worldwide.
Professor Judith Bliss and other researchers studied women with HER2 positive – one of the most aggressive types of breast cancer – after treating them with a combination of two drugs trastuzumab and lapatinib and found the tumours either shrink away or disappeared in some patients within 11 days.
The Cancer Research UK funded clinical trial was reported at the 10th European Breast Cancer Conference in Amsterdam on Thursday.
“For solid tumours to disappear in 11 days is unheard of. These are mind-boggling results, lLead researcher Nigel Bundred, professor of surgical oncology at the University of Manchester, has been quoted by The Telegraph as saying.
About one in every five reported breast cancers is HER2-positive and it is curable.